On Friday, the FDA approved Checkpoint Therapeutics, Inc.’s (NASDAQ:CKPT) Unloxcyt (cosibelimab-ipdl) for metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not ...

The best point and shoot camera needs to be small enough to fit a pocket, and affordable enough to be kind to it! Having the best point-and-shoot camera is really handy if you don't want to carry ...

Another checkpoint inhibitor has entered the fray, as Checkpoint Therapeutics has passed the FDA’s checkpoint with its PD-L1 inhibitor cosibelimab. The FDA has approved cosibelimab under the ...

“Today’s FDA approval of Unloxcyt – the first marketing approval for our company…This approval marks Checkpoint’s transformation to a commercial-stage company, with the opportunity to ...

JERUSALEM, Dec 16 (Reuters) - Check Point Software Technologies (CHKP.O), opens new tab said on Monday that Nadav Zafrir has taken over as chief executive, replacing Gil Shwed who had been CEO for ...

¥ÿÿWÂŽ}!U­‡ª l ÔÙ‡“3€ €ê} ¨ªeB¼½j@üòÛ ýóߟ À¸{‚Ñdfnaiemckgïàèäìâêæîáéåíãëçï?Ó¬úû\N/R«(± @Àƒ¡ÛR´ÊõôX ...

Dec 13 (Reuters) - The U.S Food and Drug Administration said on Friday it has approved Checkpoint Therapeutics' (CKPT.O), opens new tab drug for treatment of a type of cancer on the outer layer of ...

Strong opinions, clear points of view, international agendas. Three journalists join our presenter and go straight to the point on an international issue that’s making news. It’s controversy ...